Perinatal Outcomes With Continuous Glucose Monitoring in Gestational Diabetes: A Systematic Review and Meta-Analysis
Journal of Diabetes Science and Technology · 22.05.2026
DOI: 10.1177/19322968261443538 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Diabetes Science and Technology, online erschienen am 22.05.2026. Verfasst von Yao Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, Chin…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: natural science foundation of sichuan province, Chengdu Economic Development Zone New Economy and Science and Technology Bureau, sichuan provincial administration of traditional chinese medicine.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objectives
To evaluate the effectiveness of continuous glucose monitoring (CGM) in women with gestational diabetes mellitus (GDM), with a focus on maternal and neonatal outcomes.
Methods
PubMed, Embase, Cochrane Library, and ClinicalTrials.gov were systematically searched up to March 2026 for randomized controlled trials. Pooled mean differences (MDs) and risk ratios (RRs) with 95% confidence intervals (CIs) were calculated.
Results
Twelve studies involving 1639 women with GDM were included. The CGM use significantly improved time in range (MD = 2.52, 95% CI = 1.37 to 3.67) and was associated with a higher proportion of women requiring pharmacotherapy (RR = 1.15, 95% CI = 1.01 to 1.32). No significant differences were observed in maternal hemoglobin A1c (HbA1c) (MD = −0.11, 95% CI = −0.24 to 0.01), cesarean section (RR = 0.97, 95% CI = 0.85 to 1.10), large for gestational age (RR = 0.64, 95% CI = 0.40 to 1.02), macrosomia (RR = 1.13, 95% CI = 0.73 to 1.74), or neonatal hypoglycemia (RR = 0.86, 95% CI = 0.67 to 1.11).
Conclusions
The CGM use in women with GDM significantly improves time in range and increases the use of pharmacotherapy, but it yields no significant differences in other maternal, neonatal, or glycemic outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, China.
ORCID-Profile: Jiancheng Lai, Yikang Ouyang
Förderung
- natural science foundation of sichuan province
- Chengdu Economic Development Zone New Economy and Science and Technology Bureau
- sichuan provincial administration of traditional chinese medicine
- Academic Degree and Postgraduate Education Reform Project of Sichuan Province
- chengdu university
- Longquanyi Talent Program
Zitieren
APA
Wang, Y., Lai, J., Zeng, H., Ouyang, Y., & Li, N. (2026). Perinatal Outcomes With Continuous Glucose Monitoring in Gestational Diabetes: A Systematic Review and Meta-Analysis. Journal of Diabetes Science and Technology. https://doi.org/10.1177/19322968261443538
Vancouver
Wang Y, Lai J, Zeng H, Ouyang Y, Li N. Perinatal Outcomes With Continuous Glucose Monitoring in Gestational Diabetes: A Systematic Review and Meta-Analysis. Journal of Diabetes Science and Technology. 2026. doi:10.1177/19322968261443538
BibTeX
@article{Wang2026,
author = {Wang, Yao and Lai, Jiancheng and Zeng, Hongfei and Ouyang, Yikang and Li, Na},
title = {Perinatal Outcomes With Continuous Glucose Monitoring in Gestational Diabetes: A Systematic Review and Meta-Analysis},
journal = {Journal of Diabetes Science and Technology},
year = {2026},
doi = {10.1177/19322968261443538}
}
EUVIMED